SiriusPoint Ltd
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-06-30; filed 2024-08-01.
0001576018-24-000042
Item 1A. Risk FactorsCurrent report: 10-Q
Period ended 2024-09-30; filed 2024-10-31.
0001576018-24-000054
Item 1A. Risk FactorsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 27 previous paragraphs and 27 current paragraphs.
24 unchanged; 2 reworded; 1 added; 0 removed; 1 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
The following table summarizes our repurchase of common shares during the three months ended September 30, 2024:
Reworded paragraphs (2)
Previous wording
As of June 30, 2024, our outstanding indebtedness included $254.4 million in 2017 SEK Subordinated Notes and $394.2 million in 2024 Senior Notes.
Current wording
As of September 30, 2024, our outstanding indebtedness included $266.0 million in 2017 SEK Subordinated Notes and $394.5 million in 2024 Senior Notes.
Previous wording
On July 31, 2024, the Company’s Board of Directors authorized the Company to repurchase up to an additional $250.0 million of the Company’s common shares, which together with the amount remaining available under previously announced share repurchase authorizations, will allow the Company to repurchase up to $306.3 million of its common shares in the aggregate. The share repurchase program does not have an expiration date.
Current wording
On July 31, 2024, the Company’s Board of Directors authorized the repurchase of an additional $250.0 million common shares, which, together with the amount remaining under the share repurchase programs previously authorized on May 4, 2016 and February 28, 2018, will allow the Company to repurchase up to $306.3 million of its common shares in the aggregate. The share repurchase program does not have an expiration date.
Rearranged previous paragraphs (1)
Previous report — wording carried elsewhere
On February 28, 2018, the Company’s Board of Directors authorized the repurchase of an additional $148.3 million common shares, which, together with the amount remaining under the share repurchase program previously authorized on May 4, 2016, will allow the Company to repurchase up to $200.0 million of the Company’s outstanding common shares in the aggregate. As of June 30, 2024, a maximum value of approximately $56.3 million of common shares and warrants may yet be purchased under the program. The Company did not make any repurchases of common shares during the six months ended June 30, 2024.